PERSPECTIVE article
Front. Vet. Sci.
Sec. Veterinary Clinical, Anatomical, and Comparative Pathology
This article is part of the Research TopicInnovative Approaches in Veterinary Pathology: Diagnostics, Therapeutics, and Zoonotic Threats - volume IIView all 6 articles
Gouty Arthritis Animal Models: Limitations, Challenges, and Optimization Strategies
Provisionally accepted- 1Guangdong Institute of Traditional Chinese Medicine, Guangzhou, China
- 2Foshan Hospital of Traditional Chinese Medicine, Foshan, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Gouty arthritis (GA) is an inflammatory disease primarily triggered by the deposition of monosodium urate (MSU) crystals in and around the joints. With rising living standards and shifts in dietary patterns, the global incidence of GA is increasing, accompanied by a trend toward earlier onset. Consequently, elucidating its pathogenesis and developing effective treatments are major priorities in clinical research. Animal models of GA serve as an indispensable platform for mechanistic investigation and therapeutic development, especially for novel pharmacological agents. Current animal models of GA are broadly categorized into three types: MSU crystal-induced acute inflammation models, hyperuricemia-combined models, and those designed to simulate chronic gout and tophus formation. While existing approaches successfully replicate the acute inflammatory response characteristic of GA, they remain substantially limited in recapitulating the key features of the chronic disease phase, notably spontaneous tophus formation and persistent synovitis. This article critically examines the defining characteristics and optimal applications of prevailing GA models and proposes targeted strategies for their future optimization.
Keywords: Animal Models, Gouty arthritis, Hyperuricemia, Monosodium urate, Tophus
Received: 11 Jan 2026; Accepted: 12 Feb 2026.
Copyright: © 2026 Chen, Chen and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Long Chen
Yu Zhang
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.